Colloids and Surfaces B: Biointerfaces Biotechnology
Internalizing RGD (iRGD)-modified liposomal nanoparticles as a universal antigen-delivering platform for remodeling tumors and enhancing T-cell receptor-engineered T cell immunotherapy
The publisher did not provide an abstract — full text is available via the link below.